The Role of Radiation Therapy for Pancreatic Cancer in the Adjuvant and Neoadjuvant Settings

被引：38

作者：

Badiyan, Shahed N. ^{[1
]}

Molitoris, Jason K. ^{[2
]}

Chuong, Michael D. ^{[3
]}

Regine, William F. ^{[1
]}

Kaiser, Adeel ^{[1
]}

机构：

[1] Univ Maryland, Sch Med, Dept Radiat Oncol, Baltimore, MD 21201 USA

[2] Univ Maryland, Med Ctr, Dept Radiat Oncol, Baltimore, MD 21201 USA

[3] Baptist Hlth South Florida, Miami Canc Inst, Dept Radiat Oncol, Miami, FL USA

来源：

SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA | 2017年 / 26卷 / 03期

关键词：

Pancreatic cancer; Pancreas cancer; Adjuvant; Neoadjuvant; Chemoradiation; Radiation therapy; Proton therapy; Stereotactic body radiotherapy; PHASE-II TRIAL; FULL-DOSE GEMCITABINE; INTENSITY-MODULATED RADIOTHERAPY; INTERFERON-BASED CHEMORADIATION; STEREOTACTIC BODY RADIOTHERAPY; CARBOHYDRATE ANTIGEN 19-9; TWICE-WEEKLY GEMCITABINE; NORMAL-TISSUE EXPOSURE; RESECTABLE ADENOCARCINOMA; CONCURRENT RADIATION;

D O I：

10.1016/j.soc.2017.01.012

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Pancreatic cancer is the third leading cause of cancer-related death in the United States. Although surgery remains the only curative treatment, chemotherapy and radiation therapy are frequently used. In the adjuvant setting, radiation is usually delivered with chemotherapy to eradicate residual microscopic or macroscopic disease in the resection bed. Neoadjuvant radiation therapy has become more frequently utilized. This article reviews the historical and modern literature regarding radiation therapy in the neoadjuvant and adjuvant settings, focusing on the evolution of radiation therapy techniques and clinical trials in an attempt to identify patients best suited to receiving radiation therapy.

引用

页码：431 / +

页数：25

共 116 条

[1] FAILURE TO ADHERE TO PROTOCOL SPECIFIED RADIATION THERAPY GUIDELINES WAS ASSOCIATED WITH DECREASED SURVIVAL IN RTOG 9704-A PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY AND CHEMORADIOTHERAPY FOR PATIENTS WITH RESECTED ADENOCARCINOMA OF THE PANCREAS [J].

Abrams, Ross A. ;

Winter, Kathryn A. ;

Regine, William F. ;

Safran, Howard ;

Hoffman, John P. ;

Lustig, Robert ;

Konski, Andre A. ;

Benson, Al B. ;

Macdonald, John S. ;

Rich, Tyvin A. ;

Willett, Christopher G. .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (02) :809-816

[2] Adjuvant therapy in pancreatic cancer: Phase I trial of radiation dose escalation with concurrent full-dose gemcitabine [J].

Allen, AM ;

Zalupski, MM ;

Robertson, JM ;

Eckhauser, FE ;

Simone, D ;

Brown, D ;

Hejna, G ;

Normolle, D ;

Lawrence, TS ;

McGinn, CJ .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (05) :1461-1467

[3]

[Anonymous], 1999, Int J Radiat Oncol Biol Phys, V44, P619

[4]

[Anonymous], 2012, JCO, DOI DOI 10.1200/JCO.2012.30.15_SUPPL.4051

[5]

[Anonymous], PANCR AD

[6] The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal [J].

Ballehaninna, Umashankar K. ;

Chamberlain, Ronald S. .

JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2012, 3 (02) :105-119

[7] Postresection CA 19-9 Predicts Overall Survival in Patients With Pancreatic Cancer Treated With Adjuvant Chemoradiation: A Prospective Validation by RTOG 9704 [J].

Berger, Adam C. ;

Garcia, Miguel, Jr. ;

Hoffman, John P. ;

Regine, William F. ;

Abrams, Ross A. ;

Safran, Howard ;

Konski, Andre ;

Benson, Alan B., III ;

MacDonald, John ;

Willett, Christopher G. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (36) :5918-5922

[8] Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes [J].

Biankin, Andrew V. ;

Waddell, Nicola ;

Kassahn, Karin S. ;

Gingras, Marie-Claude ;

Muthuswamy, Lakshmi B. ;

Johns, Amber L. ;

Miller, David K. ;

Wilson, Peter J. ;

Patch, Ann-Marie ;

Wu, Jianmin ;

Chang, David K. ;

Cowley, Mark J. ;

Gardiner, Brooke B. ;

Song, Sarah ;

Harliwong, Ivon ;

Idrisoglu, Senel ;

Nourse, Craig ;

Nourbakhsh, Ehsan ;

Manning, Suzanne ;

Wani, Shivangi ;

Gongora, Milena ;

Pajic, Marina ;

Scarlett, Christopher J. ;

Gill, Anthony J. ;

Pinho, Andreia V. ;

Rooman, Ilse ;

Anderson, Matthew ;

Holmes, Oliver ;

Leonard, Conrad ;

Taylor, Darrin ;

Wood, Scott ;

Xu, Qinying ;

Nones, Katia ;

Fink, J. Lynn ;

Christ, Angelika ;

Bruxner, Tim ;

Cloonan, Nicole ;

Kolle, Gabriel ;

Newell, Felicity ;

Pinese, Mark ;

Mead, R. Scott ;

Humphris, Jeremy L. ;

Kaplan, Warren ;

Jones, Marc D. ;

Colvin, Emily K. ;

Nagrial, Adnan M. ;

Humphrey, Emily S. ;

Chou, Angela ;

Chin, Venessa T. ;

Chantrill, Lorraine A. .

NATURE, 2012, 491 (7424) :399-405

[9] Adjuvant gemcitabine and concurrent radiation for patients with resected pancreatic cancer: a phase II study [J].

Blackstock, A. W. ;

Mornex, F. ;

Partensky, C. ;

Descos, L. ;

Case, L. D. ;

Melin, S. A. ;

Levine, E. A. ;

Mishra, G. ;

Limentani, S. A. ;

Kachnic, L. A. ;

Tepper, J. E. .

BRITISH JOURNAL OF CANCER, 2006, 95 (03) :260-265

[10] Concurrent gemcitabine and radiotherapy with and without neoadjuvant gemcitabine for locally advanced unresectable or resected pancreatic cancer: A Phase I-II study [J].

Brade, Anthony ;

Brierley, James ;

Oza, Amit ;

Gallinger, Steven ;

Cummings, Bernard ;

MacLean, Martha ;

Pond, Gregory R. ;

Hedley, David ;

Wong, Shun ;

Townsley, Carol ;

Brezden-Masley, Christine ;

Moore, Malcolm .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (04) :1027-1036

← 1 2 3 4 5 6 7 8 9 10 →